AARDEX Group

AARDEX Group will be at BIO International Convention (3-6 June, 2019)

bio-international
AARDEX Group, the leader in medication adherence monitoring and management

AARDEX Group, the leader in medication adherence monitoring and management for clinical trials, will be at BIO International Convention (3-6 June, 2019).

-to discuss its experience in adherence-informed clinical trials to ensure fidelity to the research protocol
-to present its medication adherence monitoring and management ecosystem
-to share its innovative view on data-driven adherence feedback enabling digital therapeutics and patient empowerment

Come and meet us in Philadelphia (3-6 June, 2019) at the BELGIAN PAVILION, BOOTH #526

https://convention.bio.org/2019/

MEMS, medAmigo and AARDEX are AARDEX Group registered marks.

Share This Post

You may also like...

Breaking News

Enhancing Medication Adherence in Rare Disease Clinical Trials

In observance of Rare Disease Day, it is imperative to underscore the progressive strides within the domain of rare disease research. Rare diseases, characterized by their infrequent occurrence within the general populace, impose significant burdens not only on the affected